PRINCIPAL FINANCIAL GROUP INC - KERYX BIOPHARMACEUTICALS INC ownership

KERYX BIOPHARMACEUTICALS INC's ticker is KERX and the CUSIP is 492515101. A total of 120 filers reported holding KERYX BIOPHARMACEUTICALS INC in Q2 2016. The put-call ratio across all filers is 1.24 and the average weighting 0.1%.

Quarter-by-quarter ownership
PRINCIPAL FINANCIAL GROUP INC ownership history of KERYX BIOPHARMACEUTICALS INC
ValueSharesWeighting
Q3 2018$115,000
+3.6%
33,749
+13.9%
0.00%
Q2 2018$111,000
-14.0%
29,643
-5.9%
0.00%
Q1 2018$129,000
-11.0%
31,507
+0.6%
0.00%
Q4 2017$145,000
+59.3%
31,324
+145.5%
0.00%
Q3 2017$91,000
-15.0%
12,758
-13.6%
0.00%
Q2 2017$107,000
+23.0%
14,759
+4.2%
0.00%
Q1 2017$87,000
+4.8%
14,1690.0%0.00%
Q4 2016$83,000
+10.7%
14,1690.0%0.00%
Q3 2016$75,000
-18.5%
14,169
+2.0%
0.00%
Q2 2016$92,000
+7.0%
13,893
-24.4%
0.00%
Q1 2016$86,000
-3.4%
18,366
+4.8%
0.00%
Q4 2015$89,000
+43.5%
17,5270.0%0.00%
Q3 2015$62,000
-60.3%
17,527
+12.2%
0.00%
Q2 2015$156,000
-34.5%
15,623
-16.6%
0.00%
Q1 2015$238,000
+13.9%
18,743
+26.9%
0.00%
Q4 2014$209,000
-19.6%
14,766
-21.8%
0.00%
Q3 2014$260,000
-93.1%
18,876
-92.3%
0.00%
-100.0%
Q2 2014$3,780,000
-17.3%
245,776
-8.4%
0.01%
-25.0%
Q1 2014$4,571,000
+31.4%
268,222
-0.1%
0.01%
+33.3%
Q4 2013$3,478,000
-15.8%
268,575
-34.3%
0.01%
-33.3%
Q3 2013$4,129,000
+34.6%
408,875
-0.4%
0.01%
+28.6%
Q2 2013$3,068,000410,6360.01%
Other shareholders
KERYX BIOPHARMACEUTICALS INC shareholders Q2 2016
NameSharesValueWeighting ↓
VHCP Management, LLC 700,273$10,770,0005.76%
HARVEY CAPITAL MANAGEMENT INC 932,400$14,340,0005.13%
Camber Capital Management LP 3,000,000$46,140,0003.02%
Baupost Group 10,539,986$162,105,0002.64%
SECTORAL ASSET MANAGEMENT INC 3,741,656$57,547,0002.44%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 3,884,409$59,742,0002.40%
Knoll Capital Management, LLC 200,000$3,076,0001.37%
DAFNA Capital Management LLC 92,400$1,421,0001.35%
NORTHPOINTE CAPITAL LLC 892,011$13,719,0001.32%
Rhenman & Partners Asset Management AB 240,000$3,691,0001.10%
View complete list of KERYX BIOPHARMACEUTICALS INC shareholders